Details

Autor(en) / Beteiligte

• Vicuña Arregui, Miren
• Zozaya Urmeneta, José Manuel
• Martínez de Esteban, Juan Pablo
• Carral Martínez, David
• Pineda Arribas, Javier
• Forga Llenas, Lluis
• Martínez-Peñuela Virseda, José María
• Rodríguez Gutiérrez, Cristina
• Menéndez Torre, Edelmiro
• Jiménez Pérez, Francisco Javier
• Layana Echezuri, Eduardo

Titel

Study of celiac disease in adults with type 1 diabetes mellitus

Ist Teil von

• Gastroenterología y hepatología, 2010-01, Vol.33 (1), p.6-11

Ort / Verlag

Spain

Erscheinungsjahr

2010

Quelle

MEDLINE

Beschreibungen/Notizen

• Celiac disease (CD) presents a wide clinical spectrum. There are asymptomatic or oligosymptomatic forms, which are difficult to diagnose. Since patients with untreated CD can develop severe complications, early diagnosis of these forms is important. Consequently, in groups at risk for CD, such as patients with type 1 diabetes (DM1), screening through determination of antigliadin (AGA), anti-tissue transglutaminase (ATG) and antiendomysial antibodies (EMA) is recommended. In the present study, 463 DM1 patients were screened for these antibodies. Patients who were positive for one or more were offered an upper endoscopy to obtain distal duodenum biopsies. Histological lesions, when present, were classified using Marsh's classification. Of the 463 patients, 62 (13.4%) were positive for at least one of the three antibodies, and 42 accepted to undergo an endoscopy. Fourteen patients (3% of the DM1 patients) were histologically diagnosed with CD. Most of these patients had no symptoms of CD, although some showed laboratory findings frequent in CD. The presence of clinical or analytical data compatible with CD was independent of the grade of histological lesions. Finally, we calculated the sensitivity and positive predictive value for each antibody. The most sensitive were ATG and EMA. Because of the technical simplicity of determining ATG with ELISA, in our opinion, this test should be the option of choice for screening.